Previous close | 15.21 |
Open | 15.21 |
Bid | 14.80 |
Ask | 18.40 |
Strike | 240.00 |
Expiry date | 2024-01-19 |
Day's range | 15.21 - 15.21 |
Contract range | N/A |
Volume | |
Open interest | 159 |
In the latest trading session, Danaher (DHR) closed at $232.69, marking a +1.34% move from the previous day.
Danaher (DHR) closed the most recent trading day at $232.21, moving +0.76% from the previous trading session.
Beckman Coulter, a clinical diagnostics leader, today unveiled the DxI 9000 Access Immunoassay Analyzer, the most productive immunoassay analyzer per footprint. The DxI 9000 Analyzer can run up to 215 tests per hour per square meter (tests/hr/m2).
Honeywell's (HON) Q1 results benefit from strong performance of the Aerospace segment due to higher commercial aviation aftermarket sales. The company's improved guidance for 2023 holds promise.
Stocks got off to a tough start on Tuesday, as market participants looked closely at the latest slate of earnings results. United Parcel Service (NYSE: UPS) is a stalwart of the shipping industry, and its numbers say a lot about whether the e-commerce side of the consumer retail economy is firing on all cylinders. Meanwhile, Danaher (NYSE: DHR) gave its reading on the healthcare sector.
Danaher's (DHR) Q1 earnings and revenues beat estimates. However, a decline in the sale of COVID-related products weigh on the top line.
While the top- and bottom-line numbers for Danaher (DHR) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Danaher (DHR) delivered earnings and revenue surprises of 4.42% and 1.97%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Walmart, Chevron, Danaher, Intel and Lowe's are included in this Analyst Blog.
Today's Research Daily features new research reports on 16 major stocks, including Walmart Inc. (WMT), Chevron Corporation (CVX) and Danaher Corporation (DHR).
In the latest trading session, Danaher (DHR) closed at $254.76, marking a -0.54% move from the previous day.
Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Contract drug manufacturer Catalent (NYSE: CTLT) was surely tempted to reach for the aspirin bottle on Monday. Bloomberg reported that morning that the conglomerate Danaher (NYSE: DHR) has dropped its pursuit of Catalent. Citing "people familiar with the matter," the Bloomberg report said Danaher is no longer considering making a buyout offer despite its earlier expression of interest.
Steady demand across end markets within the Life Sciences segment is likely to have aided Danaher's (DHR) Q1 performance. However, cost and supply-chain woes might have hurt the same.
With their extensive reach, here are three conglomerates' investors may want to consider as they are top-rated Zack stocks at the moment.
In the latest trading session, Danaher (DHR) closed at $250.09, marking a -0.77% move from the previous day.
The DBS initiatives, cost management actions and steady demand across major end markets augur well for Danaher's (DHR) growth. Handsome rewards to shareholders add to the stock's appeal.
HTHIY vs. DHR: Which Stock Is the Better Value Option?
In the latest trading session, Danaher (DHR) closed at $243.63, marking a -1.67% move from the previous day.
NVIDIA, Visa, Toyota Motor, Costco Wholesale and Danaher are included in this Analyst Blog.
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Visa Inc. (V), and Toyota Motor Corporation (TM).
HTHIY vs. DHR: Which Stock Is the Better Value Option?
For investors looking to double their money, look for healthcare stocks that are consistently increasing revenue and earnings per share (EPS). Cigna Group (NYSE: CI), Danaher (NYSE: DHR), and IQVIA Holdings (NYSE: IQV) all have managed to generate double-digit (or higher) increases in either quarterly revenue and earnings per share, or both, over the past five years. Let's find out a bit more about these three growth stocks.
Catalent (CTLT) shares gain significantly, following a Bloomberg report about a potential acquisition of the CDMO company by Danaher, a life sciences company.
Yahoo Finance Live anchors discuss how Life Storage, Newmont, and Danaher stocks are moving following reports of M&A activity.